Skip to main content

3 articles related to "Dedifferentiated Chondrosarcoma"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 12 Apr 2021

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease

in Cancer Immunity and Immunotherapy

Sjoerd P. F. T. Nota
Ahmad Al-Sukaini
Shalin S. Patel
Francesco Sabbatino
G. Petur Nielsen
Vikram Deshpande
Jennifer H. Yearley
Soldano Ferrone
Xinhui Wang
Joseph H. Schwab

Frontiers in Oncology

doi 10.3389/fonc.2021.598001

3,224 views
9 citations

Original Research

Published on 30 Aug 2022

Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy

in Cancer Immunity and Immunotherapy

Sjoerd P. F. T. Nota
David O. Osei-Hwedieh
David L. Drum
Xinhui Wang
Francesco Sabbatino
Soldano Ferrone
Joseph H. Schwab

Frontiers in Oncology

doi 10.3389/fonc.2022.939166

4,198 views
7 citations

Case Report

Published on 17 Nov 2022

Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response

in Cancer Immunity and Immunotherapy

Amisha Singh
Steven W. Thorpe
Morgan Darrow
Janai R. Carr-Ascher

Frontiers in Oncology

doi 10.3389/fonc.2022.991724

5,395 views
9 citations